The NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
👏 Well done to our #CPFTCAMEO team ✨ awarded a symposium by @IEPAnetwork for #IEPA15 on #psychosis in mid-life.
🔎 @CPFT_NHS researchers are exploring women's #MentalHealth experiences and needs during #Menopause to learn how to improve care for them:
➡️ https://www.cpft.nhs.uk/research-news/cameo-team-deliver-symposium-on-midlife-psychosis-at-international-conference-5394
The death of the Nobel Prize-winning pioneer of DNA, James Watson, has been announced. He was 97.
Together with Francis Crick, Rosalind Franklin and Maurice Wilkins, he identified the double-helix while working @DeptofPhysics. They famously announced that they had "discovered…
🚨Cambridge researchers are leading the way in developing the world’s first cot-side functional neuroimaging system to help rapidly detect brain injuries such as cerebral palsy in newborns.
🚨 Learn more:
@CUH_NHS @Cambridge_Uni @NIHRresearch @BBCLookEast
Emergence of host-adapted Salmonella enteritidis through rapid evolution in an immunocompromised
Comparative epidemiology of incident Parkinson’s disease in Cambridgeshire, UK
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
A Comparison of Quantitative Methods for Clinical Imaging with hyperpolarized13C-Pyruvate
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching
Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury
Home Use of an Artificial Beta Cell in Type 1 Diabetes.
Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series
Direct Comparison of Virtual-Histology Intravascular Ultrasound and Optical Coherence Tomography Imaging for Identification of Thin-Cap Fibroatheroma
Preimplant Normothermic Liver Perfusion of a Suboptimal Liver Donated After Circulatory Death
Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography
Clinical application of autologous technetium-99m-labelled eosinophils to detect focal eosinophilic inflammation in the lung
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
Transcriptional regulator PRDM12 is essential for human pain perception
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events
Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetes
Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial
The Paired Associates Learning (PAL) Test: 30 years of CANTAB Translational Neuroscience From Laboratory to Bedside in Dementia Research